# Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions

> **NCT06399055** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 37 (actual)

## Conditions studied

- Endocrine, Nutritional and Metabolic Diseases

## Interventions

- **DRUG:** CKD-387
- **DRUG:** D484

## Key facts

- **NCT ID:** NCT06399055
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-16
- **Primary completion:** 2022-09-26
- **Final completion:** 2022-10-09
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06399055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06399055, "Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06399055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*